Multisite comparison of high-sensitivity multiplex cytokine assays

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1229-1242

  Breen, Elizabeth Crabb ^a,b   Reynolds, Sandra M ^c   Cox, Christopher ^c   Jacobson, Lisa P ^c   Magpantay, Larry ^b   Mulder, Candice B ^d   Dibben, Oliver ^e,k   Margolick, Joseph B ^c   Bream, Jay H ^c   Sambrano, Elise ^f   Martínez Maza, Otoniel ^b,h   Sinclair, Elizabeth ^f   Borrow, Persephone ^e   Landay, Alan L ^d   Rinaldo, Charles R ⁱ   Norris, Philip J ^g,j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^j BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASSAY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ELECTROCHEMOLUMINESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERLEUKIN 10 BLOOD LEVEL; INTERLEUKIN 1BETA BLOOD LEVEL; INTERLEUKIN 6 BLOOD LEVEL; INTERLEUKIN 8 BLOOD LEVEL; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MULTIPLEX CYTOKINE ASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR ALPHA BLOOD LEVEL; VIREMIA; VIRUS LOAD;

ADULT; CLINICAL LABORATORY TECHNIQUES; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PLASMA; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 79961117116     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05032-11     Document Type: Article

References (32)

1. Aziz, N., P. Nishanian, and J. L. Fahey. 1998. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin. Diagn. Lab. Immunol. 5:755-761. (Pubitemid 28519247)
2. Breen, E. C., et al. 2006. Elevated serum soluble CD30 (sCD30) precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma. Tumor Biol. 27:187-194.
3. Chowdhury, F., A. Williams, and P. Johnson. 2009. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J. Immunol. Methods 340:55-64.
4. Djoba Siawaya, J. F., et al. 2008. An evaluation of commercial fluorescent bead-based Luminex cytokine assays. PLoS One 3:e2535.
5. Fahey, J. L., et al. 2000. Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation. Clin. Diagn. Lab. Immunol. 7:540-548. (Pubitemid 30463209)
6. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018. (Pubitemid 24035036)
7. Fortis, C., et al. 2002. Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2. AIDS Res. Hum. Retroviruses 18:491-499. (Pubitemid 34499725)
8. Fu, Q., J. Zhu, and J. E. Van Eyk. 2010. Comparison of multiplex immunoassay platforms. Clin. Chem. 56:314-318.
9. Heinold, A., B. Kuehl, G. Brenner-Weiss, G. Opelz, and T. H. Tran. 2010. Sequential analysis by immunoprecipitation-MALDI-TOF: a novel method for detection and identification of alloantibody specificities. Hum. Immunol. 71:462-467.
10. Herold, M., U. Meise, V. Günther, H. Rössler, and R. Zangerle. 1994. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users. Presse Med. 23:1854-1858.
11. Hittinger, G., C. Poggi, E. Delbeke, N. Profizi, and A. Lafeuillade. 1998. Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients. Infection 26:100-103. (Pubitemid 28142928)
12. Kalayjian, R. C., et al. 2010. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J. Infect. Dis. 201:1796-1805.
13. Kaplan, R. C., et al. 2008. Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. J. Stroke Cerebrovasc. Dis. 17:344-355.
14. Keating, S. M., et al. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of US women. AIDS, in press.
15. Khan, S. S., M. S. Smith, D. Reda, A. F. Suffredini, and J. P. McCoy, Jr. 2004. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytom. B Clin. Cytom. 61:35-39. (Pubitemid 39223368)
16. Kofoed, K., U. V. Schneider, T. Scheel, O. Andersen, and J. Eugen-Olsen. 2006. Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin. Chem. 52:1284-1293. (Pubitemid 43956019)
17. Kuhle, J., et al. 2009. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur. J. Neurol. 16:771-774.
18. Lanteri, M. C., et al. 2009. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 119:3266-3277.
19. Liu, M. Y., et al. 2005. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin. Chem. 51:1102-1109. (Pubitemid 43079385)
20. Middleton, R. K., et al. 2007. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J. Vasc. Surg. 45:574-580. (Pubitemid 46281517)
21. Nechansky, A., S. Grunt, I. M. Roitt, and R. Kircheis. 2008. Comparison of the calibration standards of three commercially available multiplex kits for human cytokine measurement to WHO standards reveals striking differences. Biomark. Insights 3:227-235.
22. Neuhaus, J., et al. 2010. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J. Infect. Dis. 201:1788-1795.
23. Norris, P. J., et al. 2006. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV type 1 infection. AIDS Res. Hum. Retroviruses 22:757-762. (Pubitemid 44735002)
24. + elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 24: 1095-1105.
25. Reddy, M. M., and M. H. Grieco. 1991. Erythropoietin and granulocytemacrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection. Int. J. STD AIDS 2:128-132.
26. Regidor, D. L., et al. 2011. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 25:303-314.
27. Richens, J. L., et al. 2010. Quantitative validation and comparison of multiplex cytokine kits. J. Biomol. Screen. 15:562-568.
28. Roberts, L., et al. 2010. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 24:819-831.
29. Rotger, M., et al. 2010. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog. 6:e1000781. doi:10.1371/journal.ppat.1000781.
30. Stacey, A. R., et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83:3719-3733.
31. Tobler, L. H., et al. 2008. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virusinfected blood donors. J. Infect. Dis. 198:979-983.
32. Zhang, Y. J., et al. 2009. Immunoassay-based measurement of clinical biomarkers for monitoring changes in nasal cavity. J. Pharm. Biomed. Anal. 50:823-830.